Abstract
CHOLESTEROL TESTINGhas changed remarkably since the middle 1980s. Millions of asymptomatic Americans have been tested<sup>1</sup>and retested. The advent of tabletop chemistry analyzers and portable testing devices,<sup>2</sup>the introduction of medications that favorably affect atherosclerotic risk and prognosis,<sup>3-5</sup>and the dissemination of a National Cholesterol Education Program<sup>6,7</sup>have led to an increase in cholesterol awareness and intervention. An article in this issue of theArchives<sup>8</sup>concerns an important facet of this issue: the accuracy and utility of cholesterol testing and retesting. In this issue of theArchives, Forrow et al<sup>8</sup>present data on more than 1000 individuals who participated in a cholesterol screening program and then were retested 17 months later. Participants with initially high levels of cholesterol typically had lower levels at follow-up, and the authors attributed a considerable degree of the reduction to "regression to the mean." These results provide an
Keywords
CholesterolLdl cholesterolMedicineAsymptomaticEndocrinologyInternal medicine
Related Publications
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
1. The most important way to prevent atherosclerotic vascular disease, heart failure, and atrial fibrillation is to promote a healthy lifestyle throughout life. 2. A team-based ...
Prevalence of diabetes, pre-diabetes and associated risk factors: second National Diabetes Survey of Pakistan (NDSP), 2016–2017
Objective The second National Diabetes Survey of Pakistan (second NDSP) was planned to ascertain the updated prevalence of diabetes, pre-diabetes and associated risk factors at ...
A New Method of Predicting US and State-Level Cancer Mortality Counts for the Current Calendar Year
Every January for more than 40 years, the American Cancer Society (ACS) has estimated the total number of cancer deaths that are expected to occur in the United States and indiv...
Impaired Glucose Tolerance in the U. S. Population
Impaired glucose tolerance (IGT) constitutes two-thirds of all glucose intolerance in the United States and is a major risk factor for diabetes. Despite these findings, the clin...
The association of glycemia and cause-specific mortality in a diabetic population
<h3>Background:</h3> The purpose of this study was to investigate the association of glycemia with cause-specific mortality in a diabetic population. <h3>Methods:</h3> The study...
Publication Info
- Year
- 1995
- Type
- letter
- Volume
- 155
- Issue
- 20
- Pages
- 2146-2146
- Citations
- 3
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
3
OpenAlex
Cite This
Peter W.F. Wilson
(1995).
Cholesterol Screening.
Archives of Internal Medicine
, 155
(20)
, 2146-2146.
https://doi.org/10.1001/archinte.1995.00430200017004
Identifiers
- DOI
- 10.1001/archinte.1995.00430200017004